Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Support Care Cancer. 2018 Oct 24;27(6):2329–2337. doi: 10.1007/s00520-018-4496-3

Table 1.

Baseline characteristics of patient and caregiver (N=159)

Variable n (%)
Patientb
 Mean age (s.d.), years 53.3 (14.8)
   range 19–76
 Sex
   Female 56 (35.2)
   Male 103 (64.8)
 Race
   White 125 (78.6)
   Black or African-American 2 (1.3)
   Native Hawaiian or Other
   Pacific Islander 2 (1.3)
   More than one race 5 (3.1)
   Another group not listed 6 (3.8)
 Ethnicity
   Hispanic or Latino 13 (8.2)
   Non-Hispanic or Latino 121 (76.1)
 Annual income, $
   < 25,000 45 (28.3)
   25,000–44,999 28 (17.6)
   45,000–64,999 19 (11.9)
   > 65,000 30 (18.9)
 Diagnosisa
   Leukemia 97 (61.0)
   Lymphoma 21 (13.2)
   MDS/MPS 35 (22.0)
   Other 6 (3.8)
 Mean Duration of Illness (s.d.), month 19.9 (34.2)
   range 1.6–195.3
 Transplant conditioning intensity
   Myeloablative 88 (55.3)
   Non-myeloablative 17 (10.7)
   Reduce intensity 40 (25.2)
 Donor Source
   Matched Related Donor 48 (30.2)
   Matched Unrelated Donor 57 (35.8)
   Mismatched Unrelated Donor 8 (5.0)
   Cord 39 (24.5)
   Other 5 (3.1)
 Caregiverc
  Mean age (s.d.), years 54.1 (13.7)
    range 18–82
  Sex
    Female 125 (78.6)
    Male 31 (19.5)
  Race
    White 130 (81.8)
    American Indian or Alaska Native 1 (0.6)
    Black or African-American 2 (1.3)
    More than one race 6 (3.8)
    Another group not listed 6 (3.8)
  Ethnicity
    Hispanic or Latino 14 (8.8)
    Non-Hispanic or Latino 129 (81.1)
  Education
    College graduate or above 116 (73.0)
  Annual income (reported by patient), $
    < 25,000 50 (31.4)
    25,000–44,999 27 (17.0)
    45,000–64,999 31 (19.5)
    > 65,000 29 (18.2)
 Relationship
    Spouse/partner 102 (64.2)
    Parent 20 (12.6)
    Other 29 (18.2)
 Employment Status
 (Before caregiving) n (%)
    Full-time 65 (40.9)
    Part-time 27 (17.0)
    Unemployed 16 (10.1)
    On leave 2 (1.3)
    Retired 40 (25.2)
a

Abbreviations: MDS, myelodysplastic syndrome; MPS, myeloproliferative syndrome.

b

Patient information was not available for the following variables: race (n=19), ethnicity (n=25), annual income (n=37), duration of illness (n=17), transplant conditioning intensity (n=14), and donor source (n=2).

c

Caregiver information was not available for the following variables: age (n=3), sex (n=3), race (n=14), ethnicity (n=16), education (n=8), annual income (n=22), relationship (n=8), employment status before caregiving (n=9) and after caregiving (n=11).